- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- August 2024
- 99 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Zofenopril is a cardiovascular drug used to treat hypertension, congestive heart failure, and other cardiovascular conditions. It is an angiotensin-converting enzyme (ACE) inhibitor, which works by blocking the production of a hormone that causes blood vessels to narrow. This helps to reduce blood pressure and improve blood flow. Zofenopril is available in both oral and injectable forms. It is usually taken once a day, with or without food.
Zofenopril is a relatively new drug, having been approved by the US Food and Drug Administration in 2006. It is widely used in Europe and other parts of the world, but is not yet approved in the United States.
The market for Zofenopril is growing, as more people are being diagnosed with hypertension and other cardiovascular conditions. It is also becoming increasingly popular as an alternative to other ACE inhibitors, due to its lower cost and fewer side effects.
Some of the companies in the Zofenopril market include Novartis, Sanofi, Pfizer, Merck, and GlaxoSmithKline. Show Less Read more